Company page

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc. is a public biotechnology company listed under the ticker INBX, operating in the American market. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platforms. With a market capitalization of approximately $1.37 billion, Inhibrx is positioned to advance its pipeline of drug candidates.